Table 2.
Primary and secondary outcomes in the intention-to-treat (ITT) population
| Outcome | Study arm | |||||
|---|---|---|---|---|---|---|
|
Control group T1: n = 97, T2: n = 82 |
Intervention group T1: n = 105, T2: n = 85 |
|||||
| Time | Median | IQR | Median | IQR | p | |
| T1 | SPPB | 3.00 | [2.00–5.00] | 4.00 | [3.00–5.00] | 0.308a |
| Frailty scale | 5.00 | [4.00–6.00] | 5.00 | [3.00–6.00] | 0.281b | |
| Clock test | 3.00 | [2.00–4.00] | 3.00 | [2.00–4.00] | 0.799 b | |
| EQ-5D 5L VAS | 55.00 | [45.00–75.00] | 50.00 | [45.00–70.00] | 0.355 b | |
| FES-I | 28.00 | [20.00–38.00] | 27.00 | [21.00–37.00] | 0.805 b | |
| T2 | SPPB | 3.00 | [2.00–5.00] | 4.00 | [2.00–5.00] | 0.225 a |
| Frailty scale | 6.00 | [4.00–6.00] | 5.00 | [4.00–6.00] | 0.912 b | |
| Clock drawing test | 3.00 | [2.00–4.00] | 3.00 | [2.00–4.00] | 0.661 b | |
| EQ5D 5L VAS | 50.00 | [47.50–72.50] | 54.00 | [50.00–75.00] | 0.425 b | |
| FES-I | 27.00 | [20.00–38.00] | 26.00 | [20.00–35.00] | 0.964 b | |
IQR Interquartile range, FES-I Falls Efficacy Scale, SPPB Short Physical Performance Battery, VAS Visual Analogue Scale
Informative missing values were replaced by the worst outcome possible
aGeneralised linear model, controlled for the baseline SPPB score
bMann–Whitney U test if the data were not normally distributed